申请人:Roche Diagnostics GmbH
公开号:US05968982A1
公开(公告)日:1999-10-19
Pharmaceutical agents for treating diabetus mellitus which contain a compound of formula I ##STR1## as the active substance, in which A, B, A' and W have the meanings stated in the claims, new compounds of formula I as well as processes for their production.
治疗糖尿病的药物,含有式I的化合物作为活性物质,其中A、B、A'和W具有索要权利要求书中所述的含义,以及式I的新化合物以及其生产方法。